SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-032024
Filing Date
2024-07-01
Accepted
2024-07-01 18:00:33
Documents
1
Period of Report
2024-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 8379
  Complete submission text file 0001140361-24-032024.txt   9876
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
USMAN NASSIM (Reporting) CIK: 0001206872 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 241092161